A group led by Prof. Horacio Cabral, in collaboration with a group led by Prof. Kazuhiro Kakimi, discovered a new way to improve cancer immunotherapy. Their findings are published in a paper, titled “An IL-12-Based Nanocytokine Safely Potentiates Anticancer Immunity through Spatiotemporal Control of Inflammation to Eradicate Advanced Cold Tumors,” in Advanced Science.
Click here for original story, pH-activated nanocytokines based on IL-12 safely overcome cancer resistance to immunotherapy
Source: Phys.org